• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Study on the Role of TIMP1 and TIMP2 as Growth Factors in the Liver

Research Project

Project/Area Number 08670579
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Gastroenterology
Research InstitutionNAGOYA UNIVERSITY

Principal Investigator

FUKUDA Yoshihide  NAGOYA UNIVERSITY Second Department of Internal Medicine, Assistant Professor, 医学部, 講師 (40181284)

Co-Investigator(Kenkyū-buntansha) KOYAMA Yasuo  NAGOYA UNIVERSITY Second Department of Internal Medicine, Research Assistant, 医学部, 助手 (40192067)
YAMADA Masahiko  NAGOYA UNIVERSITY Health Administration Center, Nagoya Institute of Technology,, 保健管理センター, 助手 (10273319)
Project Period (FY) 1996 – 1997
Project Status Completed (Fiscal Year 1997)
Budget Amount *help
¥1,900,000 (Direct Cost: ¥1,900,000)
Fiscal Year 1997: ¥900,000 (Direct Cost: ¥900,000)
Fiscal Year 1996: ¥1,000,000 (Direct Cost: ¥1,000,000)
Keywordsfibrosis / growth factor / hepatocellular carcinoma / liver / matrix metalloproteinase / MMP / tissue inhibitors of matrix metalloproteinase / TIMP / HepG2 / Huh7
Research Abstract

Tissue inhibitors of matrix metalloproteinase (TIMPs) are specific inhibitors of matrix metalloproteinases, and three kinds of TIMPs have been identified. TIMP1 and TIMP2 have the potent growth-promoting activity for a wide range of cells. This study aimed to clarify growth-promoting activity of TIMPs in the liver using human hepatome cell lines and rat hepatocytes. HepG2 cells were found to secrete TIMPs in the serum-free media without stimulation. The concentration of TIMP2 was 7-9 times thicker than that of TIMP1. As compared with untreated FBS,removal of TIMPs from FBS showed a significant inhibition of DNA synthesis at 24 hours after incubation. Recombinant TIMPs demonstrated a dose dependent stimulatory effect. Hepatoma cell lines such as HepG2, Huh7 and PLC/PRF/5 also produced TIMP3 as well as TIMP1 and 2, which was demonstrated by estimating levels in the media and by detection of mRNA using RT-PCR.Rat hepatocytes showed significant elevations of 3H-thimidine uptake by adding bovine recombinant TIMP1. Administration of human recombinant TIMP1 resulted in no uptake of 3H-thymidine. These indicate that TIMPs function as autocrine cell growth factors in addition to inhibitors of matrix metalloproteinases. Rat liver can be applicable to the study on the precise function of TIMPs concerning liver injury by use of bovine TIMPs.

Report

(3 results)
  • 1997 Annual Research Report   Final Research Report Summary
  • 1996 Annual Research Report
  • Research Products

    (6 results)

All Other

All Publications (6 results)

  • [Publications] 片野 義明 他: "肝癌細胞の増殖とTIMP-1,2" 肝胆膵. 34(2). 233-239 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Ebata M, et al.: "Serum levels of tissue inhibitor of metalloproteinases-2 and of precursor form of matrix metalloproteinase-2 in patients with liver desease" LIVER. 17. 293-299 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Yoshiaki Katano, Yoshihide Fukuda, Isao Nakano, et al.: "Proliferation of hepatoma cells and TIMP-1, -2." Kan-tan-sui. 34 (2). 233-239 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Mieko Ebata, Yoshihide Fukuda, Isao Nakano, et al.: "Serum levels of tissue inhibitor of metalloproteinases-2 and of precursor form of matrix metalloproteinase-2 in patients with liver disease" Liver. 17. 293-299 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] 片野 義明,他: "肝癌細胞の増殖とTIMP-1,2" 肝胆膵. 34(2). 233-239 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Ebata M, et al.: "Serum levels of tissue inhibitor of metalloproteinases-2 and of precursor form of matrix metalloproteinase-2 in patients with liver disease." LIVER. 17. 293-299 (1997)

    • Related Report
      1997 Annual Research Report

URL: 

Published: 1996-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi